These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33778070)

  • 21. Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways.
    Yang Y; Zhang X; Cui H; Zhang C; Zhu C; Li L
    Neurosci Lett; 2014 May; 568():44-9. PubMed ID: 24686182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
    Yang X; Tao L; Zhu J; Zhang S
    Med Sci Monit; 2019 Dec; 25():9609-9617. PubMed ID: 31840653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.
    Li D; Qu X; Hou K; Zhang Y; Dong Q; Teng Y; Zhang J; Liu Y
    Anticancer Drugs; 2009 Jan; 20(1):59-64. PubMed ID: 19343001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
    Xia S; Zhao Y; Yu S; Zhang M
    Cancer Biother Radiopharm; 2010 Jun; 25(3):317-23. PubMed ID: 20578837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria.
    Tsuruta F; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Apr; 277(16):14040-7. PubMed ID: 11842081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.
    Weeks KL; Bernardo BC; Ooi JYY; Patterson NL; McMullen JR
    Adv Exp Med Biol; 2017; 1000():187-210. PubMed ID: 29098623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphoma.
    Lee JS; Tang SS; Ortiz V; Vo TT; Fruman DA
    Oncotarget; 2015 Nov; 6(34):35202-17. PubMed ID: 26460954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
    Sasi BK; Martines C; Xerxa E; Porro F; Kalkan H; Fazio R; Turkalj S; Bojnik E; Pyrzynska B; Stachura J; Zerrouqi A; Bobrowicz M; Winiarska M; Priebe V; Bertoni F; Mansouri L; Rosenquist R; Efremov DG
    Leukemia; 2019 Oct; 33(10):2416-2428. PubMed ID: 30872780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.
    Gao L; Yao R; Liu Y; Wang Z; Huang Z; Du B; Zhang D; Wu L; Xiao L; Zhang Y
    Mol Cell Biochem; 2017 May; 429(1-2):167-177. PubMed ID: 28176246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol induces cardiac hypertrophy by activating the AKT pathway.
    Lee H; Yoo YS; Lee D; Song EJ
    J Steroid Biochem Mol Biol; 2013 Nov; 138():307-13. PubMed ID: 23907017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PP9, a steroidal saponin, induces G2/M arrest and apoptosis in human colorectal cancer cells by inhibiting the PI3K/Akt/GSK3β pathway.
    Yao M; Li R; Yang Z; Ding Y; Zhang W; Li W; Liu M; Zhao C; Wang Y; Tang H; Wang J; Wen A
    Chem Biol Interact; 2020 Nov; 331():109246. PubMed ID: 32877639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
    Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phosphatidylinositol 3-kinase-regulated Akt-independent signaling promotes cigarette smoke-induced FRA-1 expression.
    Zhang Q; Adiseshaiah P; Kalvakolanu DV; Reddy SP
    J Biol Chem; 2006 Apr; 281(15):10174-81. PubMed ID: 16490785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
    Liu L; Zhao X; Pierre SV; Askari A
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
    Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
    Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Richter A; Fischer E; Holz C; Schulze J; Lange S; Sekora A; Knuebel G; Henze L; Roolf C; Murua Escobar H; Junghanss C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
    Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
    Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.